Riskpilot← Back to searchSign inGet full accessVet-Group Scandinavia AB
ABActiveOrg 5567227672Hangarvägen 3 AVeterinary activities · NACE 7500Est. 20079 employees
Revenue 2024
SEK 11,5M
+14% vs 2023
EBITDA margin
2.9%
+265% vs 2023
Equity ratio
11.5%
Financial strength
Net profit 2024
SEK 224K
+2821% vs 2023
| Revenue | SEK 11,5M | +14% |
| EBITDA | SEK 334K | +265% |
| Net profit | SEK 224K | +2821% |
| Total assets | SEK 1,6M | +11% |
| Equity | SEK 188K | +609% |
| Employees | 9 | — |
Legal name
Vet-Group Scandinavia AB
Org number
5567227672
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
5 februari 2007
Share capital
SEK 142 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva veterinärverksamhet och djursjukvård, grossistverksamhet inom veterinär- och djurprodukter, djurtransporter samt därmed förenlig verksamhet.
Address
Hangarvägen 3 A
Phone
+4631923737
Email
rebecca.wright@torslandadjurklinik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 10 413 | 9 699 | 10 758 | 10 078 | 11 505 |
| Staff expenses | — | — | −5 555 | −5 600 | −6 544 |
| EBITDA | 529 | 440 | 434 | 92 | 334 |
| Depreciation & amort. | −82 | −36 | −33 | −36 | −45 |
| EBIT | 447 | 404 | 401 | 56 | 289 |
| Net financials | −9 | −24 | −10 | −9 | −0 |
| Profit before tax | 438 | 380 | 391 | 17 | 289 |
| Tax | −77 | −82 | −89 | −9 | −64 |
| Net profit | 361 | 298 | 302 | 8 | 224 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 343 | 1 816 | 1 984 | 1 471 | 1 631 |
| Equity | −645 | −346 | −45 | −37 | 188 |
| Long-term debt | 681 | 511 | 151 | 0 | — |
| Short-term debt | 1 307 | 1 651 | 1 877 | 1 508 | 1 443 |
| Total debt | 1 988 | 2 162 | 2 028 | 1 508 | 1 443 |
EBITDA margin
2.9%
This company
15.8%
Market median
-82% vs market
20202024
Equity ratio
11.5%
This company
38.2%
Market median
-70% vs market
20202024
Return on equity
119.6%
This company
18.4%
Market median
+550% vs market
20202024
Net profit margin
2.0%
This company
8.1%
Market median
-75% vs market
20202024
Asset turnover
7.05×
This company
1.12×
Market median
+529% vs market
20202024
Debt / equity
7.69×
This company
0.62×
Market median
-1140% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EC | Audit | 2020 |
SR Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Vet-Group Scandinavia AB 
Djurkliniken i Vänersborg AktiebolagBoard members of Vet-Group Scandinavia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Charlotte Severin | Audit | 0 companies |
| Sandra Rebecca Uhlan Wright | Chief Executive Officer | 0 companies |
| Erik Gustaf Björkman | Deputy Board Member | 0 companies |